Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 2, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Pre Diabetes
Interventions
DIETARY_SUPPLEMENT

Eriocitrin

The selected individuals will be randomly distributed in 4 groups through random number generator program. Group A (n = 20) will receive a dose of 140 mg / d eriocitrin; Group B (n = 20) eriocitrin 280 mg / d; The C group (n = 20) 560 mg / d eriocitrin; And group D (n = 20) will receive the placebo with corn starch excipient. All doses will be packaged in Manipulation Pharmacy, and should be of the same type, color and size. Individuals will be instructed to regularly ingest a pre-dinner capsule for 12 weeks.

OTHER

Placebo

The selected individuals will be randomly distributed in 4 groups through random number generator program. Group A (n = 20) will receive a dose of 140 mg / d eriocitrin; Group B (n = 20) eriocitrin 280 mg / d; The C group (n = 20) 560 mg / d eriocitrin; And group D (n = 20) will receive the placebo with corn starch excipient. All doses will be packaged in Manipulation Pharmacy, and should be of the same type, color and size. Individuals will be instructed to regularly ingest a pre-dinner capsule for 12 weeks.

Trial Locations (1)

14800-903

"Sao Paulo State University Julio de Mesquita Filho, Faculdade de Ciências Farmacêuticas", Araraquara

All Listed Sponsors
collaborator

Ingredients by Nature TM

UNKNOWN

lead

Thais Cesar

OTHER

NCT03215043 - Effect of Eriocitrin Supplementation in Subjects With Intermediate Hyperglycemia | Biotech Hunter | Biotech Hunter